100 QUESTIONS IN CARDIOLOGY

(Michael S) #1
abnormal blood pressure response during exercise. History of

multiple sudden deaths in the family is an important risk factor.


  • Ambulatory monitoringof all patients with a diagnosis of HCM is


mandatory and this should be for at least 48 hours.


  • Exercise electrocardiographyis also mandatory. Patients with HCM


should undergo a metabolic exercise test with frequent blood

pressure monitoring (every minute during exercise and for 5

minutes during recovery). An abnormal BP response is an

important non-invasive marker of risk. The peak oxygen

consumption during the exercise also helps identify those with

significant limitation of exercise capacity.


  • Non-sustained ventricular tachycardia (5 beats rate of 120


beats) especially if repetitive, is also associated with increased

risk of sudden death.

Additional investigations in patients with syncope


In these patients, additional investigations should be aimed at

determining the mechanism.


  • Repetitive Holter recordings should be made.

  • Tilt table test and if necessary.

  • Electrophysiological study to exclude accessory pathway.


Other investigations that may be useful but not mandatory


This includes electrophysiological studies and rarely a thallium

scan for myocardial ischaemia. It is necessary to exclude significant

coronary artery disease with a coronary angiogram in patients

>40 years old, smokers or those with severe chest pain.

RReeaaddiinngg lliisstt
Spirito P, Seidman CE, McKenna WJ et al. The management of hyper-
trophic cardiomyopathy. N Engl J Med1997; 333366 : 775–85.
McKenna WJ, Camm AJ. Sudden death in hypertrophic cardiomy-
opathy. Assessment of patients at high risk. Circulation 1989; 8800 : 1489–92.
Maron BJ, Bonow RO, Cannon RO III et al. Hypertrophic cardiomy-
opathy. Interrelations of clinical manifestations, pathophysiology, and
therapy(1). N Engl J Med1987; 331166 : 780–9.
Maron BJ, Bonow RO, Cannon RO III et al. Hypertrophic cardiomy-
opathy. Interrelations of clinical manifestations, pathophysiology, and
therapy(2). N Engl J Med1987; 331166 : 844–52.

Free download pdf